HAART drugs induce mitochondrial damage and intercellular gaps and gp120 causes apoptosis

Milan Fiala1, Thomas Murphy, James MacDougall

  • 1Department of Medicine, Greater Los Angeles VA Medical Center, Los Angeles, CA, USA.

Cardiovascular Toxicology
|November 9, 2004
PubMed

Insights

Human immunodeficiency virus (HIV-1) and its proteins cause heart cell death and damage mitochondria. Highly active antiretroviral therapy (HAART) drugs also harm heart cells and blood vessels.

Area of Science:

  • Cardiovascular Science
  • Infectious Diseases
  • Toxicology

Background:

  • HIV-1 infection is linked to cardiovascular issues, but the specific roles of the virus, its proteins, and treatments like HAART are unclear.
  • While HAART reduces heart disease risk, it can cause metabolic problems and potentially coronary artery disease.

Purpose of the Study:

  • To investigate the toxic effects of HIV-1, HIV-1 glycoprotein 120 (gp120), and HAART drugs on heart and endothelial cells.
  • To understand the mechanisms behind HIV-1 and HAART-related cardiovascular complications.

Main Methods:

  • Assessed apoptosis in neonatal rat ventricular myocytes (NRVMs) and human coronary artery endothelial cells (CAECs) exposed to HIV-1, gp120, and azidothymidine (AZT).
  • Examined mitochondrial damage in cardiomyocytes.
  • Measured intercellular gaps and transendothelial electrical resistance in endothelial cells treated with HAART drugs.

Main Results:

  • HIV-1 and gp120 induced apoptosis in NRVMs and CAECs, while AZT did not.
  • Ethylisothiourea, a nitric oxide synthase inhibitor, reduced gp120-induced apoptosis.
  • AZT, HIV-1, and gp120 damaged cardiomyocyte mitochondria.
  • HAART drugs (AZT, indinavir) created gaps in endothelial cells and reduced electrical resistance.

Conclusions:

  • HIV-1 and gp120 directly cause cardiomyocyte and endothelial cell apoptosis, contributing to cardiovascular toxicity.
  • HAART medications can disrupt endothelial cell structure and mitochondria, potentially leading to vascular damage.

Related Concept Videos

Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...